In this video, part 1 of a 4-part series, panelists discuss recent advancements in ATTR-CM management.
Back
RX Review: Understanding ATTR-CM's New Era of Management
A 4-part video series tackling updates and unmet needs in ATTR-CM in the wake of the vutrisiran approval in March 2025.
RX Review: Understanding ATTR-CM's New Era of Management
Episodes
All
All
In this video, part 2 of a 4-part series, panelists discuss on recent advancements in imaging and biomarker-based diagnostics for ATTR-CM
In this video, part 3 of a 4-part series, panelists discuss the impact of recent approvals and pipeline developments on the outlook for ATTR-CM management.
In this video, the last in a 4-part series, panelists discuss how ongoing research and efforts could shape the future of ATTR-CM management.
Advertisement
Advertisement
Trending on HCPLive
1
Atacicept and Upstream Immune Targeting in IgAN With Richard Lafayette, MD
2
Culprits in Perioperative Allergy, With Kimberly Blumenthal, MD
3
Enlicitide’s FDA Approval for LDL-C Reduction and the CORALreef Outcomes Trial
4
Prior Authorization, Precision Medicine, and Eczema Remission, With Jason Hawkes, MD
5